跳至主要内容
临床试验/NCT04059341
NCT04059341Unknown不适用

Early Extracorporeal Shockwave Therapy for Erectile Dysfunction in Radically Prostatectomised Men.

Odense University Hospital1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2019年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
70
试验地点
1
主要终点
IIEF-5 Score 3

研究概览

简要总结

The purpose of this project is to assess the relationship between low intensity shock wave treatment (LI-SWT) and erectile function (ED) in patients who have undergone radical prostatectomy (RP).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

盲法说明

Sham LI-ESWT treatment.

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Radically prostatectomised men
  • Non nerve-sparing or nerve-sparing RP.
  • Age 20-80 years
  • Have been in a relationship for more than 3 months.
  • Sexually active
  • Patient can give informed consent.

排除标准

  • Men with ED of neuropathological or psychogenic origin
  • Rectal extirpation, radiation therapy to the pelvic area and recovery from any other cancer within the past 5 years are excluded.
  • Patients with heart disease prohibiting sexual activity or taking medication with antiandrogens, anticoagulant (apart from aspirin) or systemic use of glucocorticoids within 5 weeks.

研究组 & 干预措施

Active LI-ESWT

Experimental

Active group receives five sessions of low intensity extracorporeal shockwave treatment, once per week for five consecutive weeks. Treatment is initiated three weeks after radical prostatectomy and is given using DUOLITH® SD1 manufactured by STORZ MEDICAL AG.

干预措施: Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) (Device)

Sham

Sham Comparator

Sham group receives five sessions of sham low intensity extracorporeal shockwave treatment, once per week for five consecutive weeks. Treatment is initiated three weeks after radical prostatectomy and is given using DUOLITH® SD1 manufactured by STORZ MEDICAL AG with a shockwave absorbing adapter.

干预措施: Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) (Device)

结局指标

主要结局

IIEF-5 Score 3

时间窗: Three months after final treatment session

Change in International Index of Erectile Function (IIEF-5) score compared to baseline

IIEF-5 Score 6

时间窗: Six months after final treatment session

Change in International Index of Erectile Function (IIEF-5) score compared to baseline

IIEF-5 Score 1

时间窗: One month after final treatment session

Change in International Index of Erectile Function (IIEF-5) score compared to baseline

次要结局

  • RigiScan(One month after final treatment session)
  • EDITS(One month after final treatment session)
  • EHS 6(Six months after final treatment session)
  • EHS 1(One month after final treatment session)
  • EHS 3(Three months after final treatment session)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lars Lund,MD

Professor

Odense University Hospital

研究点 (1)

Loading locations...

相似试验